
Biocon Awarded $68m Malaysian Contract to Supply Biosimilar Insulin and Pens
Indian pharmaceutical company, Biocon has been awarded a three-year contract from the Ministry of Health in Malaysia to supply recombinant human insulin formulations. The drug, manufactured by Biocon is the country’s first locally manufactured biosimilar […]